CMS Issues Moratorium on DMEPOS Supplier Enrollment to Combat Fraud
On February 25, the Centers for Medicare & Medicaid Services (CMS) declared a six-month pause on the enrollment of new suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) into Medicare. This decision stems from concerns regarding fraudulent billing practices identified among these suppliers. The moratorium aims to curb these practices and is part of a broader initiative to enhance the integrity of Medicare and Medicaid programs.
The announcement was delivered at the White House with attendance from Vice President J.D. Vance, Health and Human Services Secretary Robert F. Kennedy Jr., and CMS Administrator Mehmet Oz, M.D. According to CMS, the decision relies on extensive data analysis involving current and historical Medicare enrollment data, reviewing metrics on supplier types, and identifying potential fraud indicators such as revoked billing privileges and ongoing investigations since 2023.
The Department of Health and Human Services (HHS) Office of the Inspector General (OIG) has frequently highlighted concerns about fraudulent activities within the DMEPOS sector, noting significant improper payments over the years. Reports from the OIG have outlined persistent vulnerabilities in the payment safeguarding mechanisms related to DMEPOS suppliers, pointing to the potential for patient harm due to unnecessary or substandard equipment.
The imposed moratorium affects seven specific types of medical supply companies, differentiated by the personnel employed, such as orthotics, prosthetics, pedorthics, pharmacists, and respiratory therapists. Suppliers principally engaged in DMEPOS provision will be subject to the suspension; however, entities where DMEPOS is not the primary function, such as pharmacies and inpatient/outpatient providers, will not face restrictions.
CMS also announced stringent scrutiny of applications during this moratorium, including site visits and extensive review processes to prevent circumvention. The agency warned that any submission of false or misleading information could result in a denial of enrollment and a reapplication bar of up to 10 years. The agency will enhance transparency by publishing details of providers and suppliers whose Medicare participation has been revoked, including specific identifiers and revocation reasons.
Furthermore, CMS announced the temporary deferral of $259.5 million in federal Medicaid funding to Minnesota due to unresolved program integrity issues, emphasizing the significant expenditures identified as unsupported or potentially fraudulent. Robert F. Kennedy Jr. highlighted the importance of modernizing fraud detection, stating, "We are replacing the old ‘pay and chase’ model with a real-time ‘detect and deploy’ strategy." Similarly, Mehmet Oz underscored the shift towards preventative measures to protect taxpayer funds and ensure program reliability for beneficiaries. The updates mark a significant development in CMS's ongoing efforts to enhance Medicare and Medicaid compliance and integrity.